KQN-59568-79869 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-23
Dose 1 — Pfizer-BioNTech
2022-01-04
Registered in v-safe
2022-01-04
Survey response — day 42, dose 1
MedDRA: Blood pressure increased, Dyspnoea, Emergency care, Headache, Tachycardia, Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: headaches, 4-5 days post vaccine experienced tachycardia, SOB, elevated BP, 60 min post vaccine had hives. Tachycardia required an ER visit.

MedDRA releases: 2024-11 · check-in free text available
2022-01-04
Report sent to call center — day 42, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-01-05
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2022-02-22
Survey response — 3 months, dose 1
MedDRA: Dyspnoea, Musculoskeletal pain, Pain in extremity — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Shortness of breath. Left should blade ache and arm ache.

MedDRA releases: 2024-11 · check-in free text available
2022-02-22
Report sent to call center — 3 months, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-23
Call 1 — Left Voicemail
2022-02-23
Call successful
Reported to VAERS during previous contact from GDIT

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-23	Pfizer-BioNTech	No

Call center

2 call center cases

2 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 10 — day 42, dose 1

2022-01-04

Symptoms: headaches, 4-5 days post vaccine experienced tachycardia, SOB, elevated BP, 60 min post vaccine had hives. Tachycardia required an ER visit.

Release 11 — 3 months, dose 1

2022-02-22

Symptoms: Shortness of breath. Left should blade ache and arm ache.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Blood pressure increased	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Emergency care	·	·	✓
SD	Headache	·	·	✓
SD	Musculoskeletal pain	·	·	✓
SD	Pain in extremity	·	·	✓
SD	Tachycardia	·	·	✓
SD	Urticaria	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release